MyHealthChecked PLC
("MyHealthChecked" or "the Company")
Directorate Change
MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that Nicholas Edwards, Chief Financial Officer will leave the business on 31 July 2023. Non-Executive Director Lesley Innes FCA, a qualified chartered accountant, will take over Board responsibility for the Company's Finance function.
Penny McCormick, Chief Executive Officer of MyHealthChecked, said: "I would like to thank Nick for the role he has played in the past 15 months at MyHealthChecked. In Lesley we have a highly skilled qualified accountant with significant PLC experience who will provide financial leadership moving forward.
"As we focus on a growth drive of our new Wellness portfolio, we will continue to review our commercial investments alongside our operational cost base to ensure that we retain a strong cash position.
"We wish Nick well in his future endeavours."
For further information contact:
|
MyHealthChecked PLC |
||
|
Penny McCormick, Chief Executive Officer |
via Walbrook PR |
|
|
SPARK Advisory Partners Limited (NOMAD) |
Tel: +44 (0)20 3368 3550 |
|
|
Neil Baldwin / Jade Bayat |
||
|
Dowgate Capital Limited (Broker) |
Tel: +44 (0)20 3903 7715 |
|
|
David Poutney / Nicholas Chambers |
||
|
Walbrook PR Ltd (Media & IR) |
Tel: +44 (0)20 7933 8780 or [email protected] |
|
|
Paul McManus / Alice Woodings |
Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 |
|
About MyHealthChecked PLC (https://investors.myhealthchecked.com/)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests will also be made available online and will be viable for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.